08189 TEDA BIOMEDICAL
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 0.75X | Oper Margin | N/A |
|---|---|---|---|
| LT Debt/Equity | 70.3% | Net Margin | N/A |
| Total Debt/Equity | 897.7% | Return on Equity | N/A |
| Price/Book | 45.31X | Return on Assets | N/A |
| (HKD 0.290) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | -101.09 | -29.57 | -22.22 | -30.78 | -51.68 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -241.9 | -33.1 | +27.8 | +40.5 | +9.3 |
| Earnings Per Share (HKD) | -0.049 | -0.016 | -0.012 | -0.016 | -0.027 |
| Earnings Per Share Growth (%) | -211.5 | -33.3 | +27.8 | +40.7 | +9.3 |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
| P/E* (X) | N/A | N/A | N/A | N/A | N/A |
| Yield (%) | N/A | N/A | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
| Book NAV (HKD) | 0.006 | 0.012 | 0.029 | 0.042 | 0.065 |
| Auditors' Opinion | N/A | Unqualified | Unqualified # | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 522.967 | 386.425 | +35.3 | 406.585 |
| Operating Result | -104.717 | -38.166 | +174.4 | -17.417 |
| Associates | -0.003 | 0 | N/A | 0 |
| Profit Before Taxation | -112.936 | -36.36 | +210.6 | -17.614 |
| Taxation | 0.609 | -0.221 | -375.6 | -1.044 |
| Profit /( Loss) After Taxation | -113.545 | -36.139 | +214.2 | -16.57 |
| Minority Interests | -22.724 | -8.337 | +172.6 | 3.589 |
| Net Profit | -90.82 | -27.802 | +226.7 | -20.159 |
| Earnings Per Share () | -0.0486 | -0.0156 | +211.5 | -0.0117 |
| Announcement Date | 2026-03-31 | 2025-03-31 | NA | 2024-03-28 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
